Journal
IMMUNITY
Volume 36, Issue 4, Pages 623-634Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2012.01.020
Keywords
-
Categories
Funding
- National Institutes of Health [R01AI067472, AI058680]
- National Multiple Sclerosis Society [RG3666, PP1734]
- Grants-in-Aid for Scientific Research [22240089] Funding Source: KAKEN
Ask authors/readers for more resources
Interleukin 9 (IL-9) is a pleiotropic cytokine that can regulate autoimmune responses by enhancing regulatory CD4(+)FoxP3(+) T regulatory (Treg) cell survival and T helper 17 (Th17) cell proliferation. Here, we analyzed the costimulatory requirements for the induction of Th9 cells, and demonstrated that Notch pathway cooperated with TGF-beta signaling to induce IL-9. Conditional ablation of Notch1 and Notch2 receptors inhibited the development of Th9 cells. Notch1 intracellular domain (NICD1) recruited Smad3, downstream of TGF-beta cytokine signaling, and together with recombining binding protein (RBP)-J kappa bound the II9 promoter and induced its transactivation. In experimental autoimmune encephalomyelitis (EAE), Jagged2 ligation regulated clinical disease in an IL-9-dependent fashion. Signaling through Jagged2 expanded Treg cells and suppressed EAE when administered before antigen immunization, but worsened EAE when administered concurrently with immunization by favoring Th17 cell expansion. We propose that Notch and Smad3 cooperate to induce IL-9 and participate in regulating the immune response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available